June 15, 2020 / 5:17 AM / a month ago

BRIEF-Valneva Partners With Batavia Biosciences For Polio Vaccine

June 15 (Reuters) - VALNEVA SE:

* BATAVIA BIOSCIENCES AND VALNEVA COLLABORATE TO ACCELERATE DEVELOPMENT OF LOW-COST INACTIVATED POLIO VACCINE

* VALNEVA WILL RECEIVE AN UPFRONT PAYMENT AND MONTHLY SERVICE FEES

* TO MANUFACTURE SIPV VACCINE FOR CLINICAL TRIAL PURPOSES IN ITS STATE-OF—ART GMP POLIO MANUFACTURING FACILITY OPERATED UNDER GAPIII POLIO CONTAINMENT

* BATAVIA WILL REMAIN RESPONSIBLE FOR RELEASE AND SUPPLY OF GMP VACCINE TO DCVMS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below